1. Home
  2. FLYX vs ALMS Comparison

FLYX vs ALMS Comparison

Compare FLYX & ALMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FLYX
    SELLHOLDBUYas of 2 days ago
  • ALMS
    SELLHOLDBUYas of 2024 years ago
  • Stock Information
  • Founded
  • FLYX 2015
  • ALMS 2021
  • Country
  • FLYX United States
  • ALMS United States
  • Employees
  • FLYX N/A
  • ALMS N/A
  • Industry
  • FLYX Blank Checks
  • ALMS
  • Sector
  • FLYX Finance
  • ALMS
  • Exchange
  • FLYX Nasdaq
  • ALMS NYSE
  • Market Cap
  • FLYX 264.1M
  • ALMS 260.6M
  • IPO Year
  • FLYX N/A
  • ALMS 2024
  • Fundamental
  • Price
  • FLYX $3.19
  • ALMS $5.64
  • Analyst Decision
  • FLYX
  • ALMS Strong Buy
  • Analyst Count
  • FLYX 0
  • ALMS 7
  • Target Price
  • FLYX N/A
  • ALMS $28.17
  • AVG Volume (30 Days)
  • FLYX 11.9K
  • ALMS 1.2M
  • Earning Date
  • FLYX 01-01-0001
  • ALMS 05-15-2025
  • Dividend Yield
  • FLYX N/A
  • ALMS N/A
  • EPS Growth
  • FLYX N/A
  • ALMS N/A
  • EPS
  • FLYX N/A
  • ALMS N/A
  • Revenue
  • FLYX $327,274,000.00
  • ALMS N/A
  • Revenue This Year
  • FLYX $4.63
  • ALMS N/A
  • Revenue Next Year
  • FLYX $33.97
  • ALMS N/A
  • P/E Ratio
  • FLYX N/A
  • ALMS N/A
  • Revenue Growth
  • FLYX 3.78
  • ALMS N/A
  • 52 Week Low
  • FLYX $1.79
  • ALMS $3.18
  • 52 Week High
  • FLYX $8.39
  • ALMS $13.53
  • Technical
  • Relative Strength Index (RSI)
  • FLYX 48.68
  • ALMS N/A
  • Support Level
  • FLYX $3.01
  • ALMS N/A
  • Resistance Level
  • FLYX $3.53
  • ALMS N/A
  • Average True Range (ATR)
  • FLYX 0.27
  • ALMS 0.00
  • MACD
  • FLYX -0.00
  • ALMS 0.00
  • Stochastic Oscillator
  • FLYX 35.38
  • ALMS 0.00

Stock Price Comparison Chart: FLYX vs ALMS

FLYX
ALMS
2024FebruaryMarchAprilMayJuneJulyAugustSeptemberOctoberNovemberDecember2025FebruaryMarch02468101214161820FLYX VS ALMS

About FLYX flyExclusive Inc.

flyExclusive Inc is an owner and operator of curated private aviation experiences dedicated to surpassing passenger expectations for quality, convenience, and safety. Its mission is to be the world's majority vertically integrated private aviation company through capital-efficient program growth, an industry pricing model, optimal dispatch availability, in-house training, and a controlled premium customer experience on modernized aircraft. The company has over 90 aircraft in its owned and leased fleet which includes light, midsize, super-midsize, and large jets. As one of the nation's Citation operators, it has curated a versatile fleet of Citation CJ3/CJ3 plus, Citation Excel/XLS/XLS plus, Citation Encore/Encore plus, Citation Sovereign, and Citation X aircraft.

About ALMS ALUMIS INC

Alumis Inc is a clinical-stage biopharmaceutical company focused on identifying, acquiring, and accelerating the development and commercialization of transformative medicines for autoimmune disorders. The Company leverages its proprietary precision data analytics platform, biological insights, and a team of experts with deep experience in precision medicine drug discovery, development, and immunology, to create medicines that significantly improve the lives of patients by replacing broad immunosuppression with targeted therapies.

Share on Social Networks:

0

By browsing this website, you accept our Privacy Policy & Terms of Use